Healthcare Tribune France
SEE OTHER BRANDS

The best news from France on health and wellness

Healthcare Tribune France: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Tribune France.

Press releases published on July 16, 2025

Circle Cardiovascular Imaging Unveils Advanced Plaque  for the Analysis of Coronary Artery Disease

Circle Cardiovascular Imaging Unveils Advanced Plaque for the Analysis of Coronary Artery Disease

Empowering Hospitals with Direct Access to Innovation and Reimbursement MONTREAL, QUEBEC, CANADA, July 16, 2025 /⁨EINPresswire.com⁩/ -- Circle Cardiovascular Imaging (Circle CVI), a global leader in cardiovascular advanced post-processing imaging, …

ABL Diagnostics Signs Distribution Agreement with Anatech to Expand Molecular Detection in South Africa, Southern Africa

ABL Diagnostics Signs Distribution Agreement with Anatech to Expand Molecular Detection in South Africa, Southern Africa

WOIPPY, FRANCE, July 16, 2025 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce a distribution agreement with Anatech Instruments (Pty) Ltd (https:// …

Press Release: Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration

Press Release: Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration

Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration Designation earned for a one-time intravitreal gene therapy designed to inhibit two key complement cascade pathways Geographic atrophy …

Communiqué de presse : Le SAR446597 de Sanofi a obtenu la désignation « fast track » aux États-Unis pour le traitement de l’atrophie géographique liée à la dégénérescence maculaire liée à l’âge

Communiqué de presse : Le SAR446597 de Sanofi a obtenu la désignation « fast track » aux États-Unis pour le traitement de l’atrophie géographique liée à la dégénérescence maculaire liée à l’âge

Le SAR446597 de Sanofi a obtenu la désignation « fast track » aux États-Unis pour le traitement de l’atrophie géographique liée à la dégénérescence maculaire liée à l’âge Cette désignation a été obtenue pour une thérapie génique intravitréenne à …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service